Body composition, sex steroids, IGF-1, and bone mineral status in aging men - PubMed (original) (raw)
Body composition, sex steroids, IGF-1, and bone mineral status in aging men
G Ravaglia et al. J Gerontol A Biol Sci Med Sci. 2000 Sep.
Abstract
Background: Bone loss in elderly men is associated with changes in body composition and reduced secretion of endogenous anabolizing hormones. The independent influences of body composition and endocrine factors on male bone metabolism, however, are unclear.
Methods: Bone mass density (BMD) (bone mass content [BMC, g]/projected bone area [BA, cm2]) at different skeletal sites, skeletal muscle, and body fat mass were measured by dual-energy X-ray absorptiometry in 129 men aged 20 to 95 years. Free testosterone, 17-beta-estradiol, dehydroepiandrosterone-sulfate, and insulin-like growth factor 1 (IGF-1) serum concentrations were measured. Because BMD may fail to control for differences in skeletal size, the associations of bone mass with body composition and hormones were studied by comparing BMD regression models incorporating age and knee height only with BMC regression models also incorporating BA.
Results: Skeletal muscle had close associations (p at least < .01) with BMD and BMC at almost all skeletal sites, but the strength of these associations was generally reduced in BMC with respect to BMD models. Weak associations (p < .05) were found in both models for fatness with femoral bone and for 17-beta-estradiol with total body and femoral bone. The association of 17-beta-estradiol with spinal bone was significant (p < .05) in the BMD but not in the BMC model. No association of BMC or BMD with androgens and IGF-1 reached significancy.
Conclusions: Skeletal muscle may be more important than fatness and anabolizing hormones in preserving bone mass in elderly men. In contrast to traditional belief, estrogens may be more important than androgens and IGF-1 in male bone metabolism.
Similar articles
- Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. van den Beld AW, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3276-82. doi: 10.1210/jcem.85.9.6825. J Clin Endocrinol Metab. 2000. PMID: 10999822 Clinical Trial. - Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
Gürlek A, Gedik O. Gürlek A, et al. J Endocrinol Invest. 2001 Jun;24(6):408-14. doi: 10.1007/BF03351040. J Endocrinol Invest. 2001. PMID: 11434664 - Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men.
Rudman D, Drinka PJ, Wilson CR, Mattson DE, Scherman F, Cuisinier MC, Schultz S. Rudman D, et al. Clin Endocrinol (Oxf). 1994 May;40(5):653-61. doi: 10.1111/j.1365-2265.1994.tb03018.x. Clin Endocrinol (Oxf). 1994. PMID: 8013146 - Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management.
Ebeling PR. Ebeling PR. Drugs Aging. 1998 Dec;13(6):421-34. doi: 10.2165/00002512-199813060-00002. Drugs Aging. 1998. PMID: 9883398 Review. - The male climacterium: clinical signs and symptoms of a changing endocrine environment.
van den Beld AW, Lamberts SW. van den Beld AW, et al. Prostate Suppl. 2000;10:2-8. doi: 10.1002/1097-0045(2000)45:10+<2::aid-pros2>3.0.co;2-y. Prostate Suppl. 2000. PMID: 11056486 Review.
Cited by
- Effects of knee extensor muscle strength on the incidence of osteopenia and osteoporosis after 6 years.
Matsui Y, Takemura M, Harada A, Ando F, Shimokata H. Matsui Y, et al. J Bone Miner Metab. 2014 Sep;32(5):550-5. doi: 10.1007/s00774-013-0528-8. Epub 2013 Nov 7. J Bone Miner Metab. 2014. PMID: 24196869 - Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study.
Cauley JA, Ewing SK, Taylor BC, Fink HA, Ensrud KE, Bauer DC, Barrett-Connor E, Marshall L, Orwoll ES; Osteoporotic Fractures in Men Study (MrOS) Research Group. Cauley JA, et al. J Clin Endocrinol Metab. 2010 Sep;95(9):4314-23. doi: 10.1210/jc.2009-2635. Epub 2010 Jun 16. J Clin Endocrinol Metab. 2010. PMID: 20554716 Free PMC article. - Androgen therapy in the aging male.
Lunenfeld B. Lunenfeld B. World J Urol. 2003 Nov;21(5):292-305. doi: 10.1007/s00345-003-0366-8. Epub 2003 Oct 24. World J Urol. 2003. PMID: 14576959 Review. - Role of sex steroids in the regulation of bone morphology in men. The MINOS study.
Szulc P, Uusi-Rasi K, Claustrat B, Marchand F, Beck TJ, Delmas PD. Szulc P, et al. Osteoporos Int. 2004 Nov;15(11):909-17. doi: 10.1007/s00198-004-1635-0. Epub 2004 Jul 3. Osteoporos Int. 2004. PMID: 15235765 - Muscle-Bone Interactions Across age in Men.
Palmer IJ, Runnels ED, Bemben MG, Bemben DA. Palmer IJ, et al. J Sports Sci Med. 2006 Mar 1;5(1):43-51. eCollection 2006. J Sports Sci Med. 2006. PMID: 24198680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous